Send feedback

CD3E p.Ser129=

c.387G>A · rs200193595 · VCV1120334

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.09%, sas)
Conditions
1
immunodeficiency 18

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -12GERP -4
Overall
CADD0.228PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.09% South Asian · 82/91,064 alleles
Filtering AF 0.0743% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0685%
Overall 0.00651% 105/1,614,072 alleles · ultra-rare
Ancestry group Frequency 1 in
South Asiangrpmax 0.09% 1,111
East Asian 0.00223% 44,892
European (non-Finnish) 0.00169% 59,001
Admixed American 0.00167% 60,026
Remaining individualsnot grpmax-eligible 0.0016% 62,504

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CD3E
Protein
p.Ser129=
Coding
c.387G>A
MANE Select
NM_000733
dbSNP
rs200193595
Type
single nucleotide variant
Location
chr11:118313741 (GRCh38)
Gene constraint
LOEUF 0.659 · pLI 0.47 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 73.56 · 44 PDB
Residue 129
an α-helix
Full CD3E gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

immunodeficiency 18 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cd3e-p-ser129 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown